Overview
Nicholas Mark is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Seattle, Washington. Dr. Mark is rated as an Experienced provider by MediFind in the treatment of Cannabinoid Hyperemesis Syndrome (CHS). His top areas of expertise are Cannabinoid Hyperemesis Syndrome (CHS) and COVID-19. Dr. Mark is currently accepting new patients.
His clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Cannabinoid Hyperemesis Syndrome (CHS).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
500 17th Ave, Seattle, WA 98122
747 Broadway, Seattle, WA 98122
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Phillip Gregoire is an Intensive Care Medicine provider in Everett, Washington. Dr. Gregoire is rated as an Experienced provider by MediFind in the treatment of Cannabinoid Hyperemesis Syndrome (CHS). His top areas of expertise are Cannabinoid Hyperemesis Syndrome (CHS) and Liver Failure. Dr. Gregoire is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cannabinoid Hyperemesis Syndrome (CHS)
- COVID-19Dr. Mark isExperienced. Learn about COVID-19.